RJA
MODV

Raymond James & Associates’s ModivCare MODV Stock Holding History

Raymond James & Associates’s Portfolio MODV Stock Details MODV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-10,930
Closed -$287K – 4062
2024
Q2 		$287K Sell
10,930
-87
-0.8% -$2.2K ﹤0.01% 3402
2024
Q1 		$258K Buy
11,017
+452
+4% +$16.6K ﹤0.01% 3463
2023
Q4 		$465K Sell
10,565
-487
-4% -$19.2K ﹤0.01% 3000
2023
Q3 		$348K Sell
11,052
-4,249
-28% -$166K ﹤0.01% 3103
2023
Q2 		$692K Buy
15,301
+167
+1% +$9.93K ﹤0.01% 2712
2023
Q1 		$1.27M Buy
15,134
+577
+4% +$55.5K ﹤0.01% 2303
2022
Q4 		$1.31M Buy
14,557
+5,905
+68% +$527K ﹤0.01% 2277
2022
Q3 		$862K Buy
8,652
+1,454
+20% +$151K ﹤0.01% 2497
2022
Q2 		$608K Buy
7,198
+475
+7% +$48K ﹤0.01% 2789
2022
Q1 		$776K Buy
+6,723
New +$776K ﹤0.01% 2769
2021
Q2 		– Sell
-5,313
Closed -$787K – 4158
2021
Q1 		$787K Buy
5,313
+509
+11% +$79.1K ﹤0.01% 2673
2020
Q4 		$666K Buy
+4,804
New +$596K ﹤0.01% 2612

Other funds holding MODV

CCM
Coliseum Capital Management Rowayton, Connecticut $1.22B AUM 18.72% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
HVCM
HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return
QGA
Q Global Advisors Fort Worth, Texas $113M AUM 20.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
ACB
Aristotle Capital Boston Boston, Massachusetts $1.61B AUM 19.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Raymond James & Associates's MODV Position: Q3 2024 in Review

Raymond James & Associates sold out of ModivCare (MODV) in Q3 2024, closing a stake of 10,930 shares — an estimated $287K sold.

Raymond James & Associates first reported a position in MODV in Q4 2020 and held it in 12 quarters. The position peaked at $1.31M in Q4 2022. 108 funds tracked by Wall St. Rank hold MODV as of Q3 2024.

  • Raymond James & Associates reported no remaining ModivCare position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 10,930 ModivCare shares in Q3 2024, an estimated $287K.
  • Raymond James & Associates first reported a position in ModivCare in Q4 2020 and held it in 12 quarters.
  • Raymond James & Associates's ModivCare position peaked at $1.31M in Q4 2022.
  • 108 funds tracked by Wall St. Rank held ModivCare as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.